In small randomized, placebo-controlled clinical trials of NAFLD and control patients, resveratrol supplementation had minimal effect on hepatic steatosis, insulin sensitivity, plasma markers of inflammation, and antioxidants [83,84]. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.